Johnson & Johnson

NYSE: JNJ
$150.13
+$0.04 (+0.0%)
Closing price February 14, 2020

How the Coronavirus Will Harm GDP and Businesses in 2020

The worst issue to consider in any viral and contagious outbreak is the suffering from illness and the loss of life. As of February 13, 2020, there were more than ...
Read Full Story »

Why Johnson & Johnson Stock Is Not Reacting More Positively to Earnings

Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2019 results before markets opened Wednesday. The health care giant reported quarterly adjusted diluted earnings per share (EPS) of $1.88 on revenue of ...
Read Full Story »

American Express, IBM, Intel, Johnson & Johnson and More Dow Stocks Reporting This Week

Seven of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week. The Dow keeps hitting all-time highs, and earnings season has only ...
Read Full Story »

2020 Bull/Bear Outlook Sees the Dow Rising to 30,650 Before Year-End

Now that 2019 has turned into 2020, it's important to reflect on the great stock market gains of 2019. It is even more important to try to figure out where ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Activision, Amazon, Apple, Boeing, Eli Lilly, J&J, Lennar, Nio, Nvidia, Tesla and More

Stocks have risen into year-end and exceeded almost all targets from a year ago, but the last trading day of the year is looking directionless after year-end profit-taking was seen ...
Read Full Story »

The 6 Most Shorted Dow Stocks

It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components. Short sellers are betting on these companies to fail, or ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Applied Materials, Barrick Gold, Best Buy, Blackstone, Boeing, Cisco, J&J, KKR, McDonald’s, Micron, Occidental, RealReal, Splunk and More

Stocks were mixed and looking for direction on Thursday despite news of President Trump's impeachment. Stocks hit all-time highs again this week. Investors rightfully have moved away from those imminent ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alcoa, Bed Bath & Beyond, Boeing, CenturyLink, DuPont, FedEx, Groupon, J&J, Micron, Microsoft, WPX Energy and More

Stocks have hit all-time highs on the heels of phase announced but unsigned trade pact between the United States and China, but Tuesday morning was looking like a mild session ...
Read Full Story »

Meet the Preliminary 2020 Dogs of the Dow

With 2019 coming to a rapid end, it's important to reflect on what happened in the past year. Still, it's more important to reflect on what 2020 will look like. ...
Read Full Story »

Why These 3 Biotechs More Than Doubled on Monday

Monday was a breakout day for a few biotech companies. Some made absolutely massive runs, practically doubling and then some. The biotechnology sector is pushing near all-time highs, and a ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amarin, Baker Hughes, Canopy Growth, Home Depot, Intelsat, J&J, Replimune, Schlumberger, Transocean and More

Markets have hit new highs recently, but the main indexes were all marginally lower on Wednesday morning. With the Dow Jones industrials up over 28,000 and the S&P 500 over ...
Read Full Story »

How Dow 28,000 Can Rapidly Become Dow 30,000 and Even Higher in 2020

Investors love seeing the stock market hit new highs. It's impressive enough for the Dow Jones industrial average to have hit 28,000 and for the S&P 500 to have hit ...
Read Full Story »

As the Dow Hits All-Time High, Over Half of Dow Stocks Keep Disappointing Investors

When investors hear that the stock market just hit a new all-time high, it's probably fairly easy to assume that this means almost all the individual stocks are probably at ...
Read Full Story »

Why Goldman Sachs Enhanced Income Strategy May Be Perfect for 2020

Even though the S&P 500 now sits at all-time highs after over 10 years of a bull market, the venerable index still offers a 1.9% dividend yield and 6% expected ...
Read Full Story »

J&J Gets $10 Billion Gift as Lab Results Show No Asbestos in Baby Powder

Johnson & Johnson (NYSE: JNJ) has found itself involved in more controversy than the company would prefer to see. The consumer and health products company has been dogged in the ...
Read Full Story »